Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...
Gottlieb was commissioner of the Food and Drug Administration from 2017 to 2019. When Makena, a drug designed to prevent preterm births, hit the market in 2011 at $1,500 per dose, it drew rife ...
Add Yahoo as a preferred source to see more of our stories on Google. Patients have been buying compounded weight loss drugs at lower prices than brand-name medications amid shortages of tirzepatide ...
Study on compounded GLP-1s uncovers use of additives and questionable sterility practices, revealing legally ‘murky’ area.
The US Food and Drug Administration (FDA) late Friday issued revised versions of two final guidance documents explaining the use of bulk drug substances in compounding and clarifying that the agency ...
If you’ve received medication through popular telemedicine companies like Hims & Hers Health, you’re probably familiar with drug compounding. That’s the process of creating customized medicine for a ...
The US Food and Drug Administration (FDA) recently issued warning letters to more than 40 compounding pharmacies, demanding that they cease certain advertising practices for a variety of compounded ...
LONDON, March 23, 2026 /PRNewswire/ -- The global animal drug compounding market is growing steadily, expected to be valued at around US$1.5 in 2026 and projected to reach US$2.3 by 2033, with a CAGR ...
The Pew Charitable Trusts released a report Tuesday, shedding light on an industry that has been recently tied to a number of instances of patient harm and death: custom-blending medications. The ...
Despite Novo Nordisk (NVO) recently ending a partnership with Hims & Hers Health (NYSE:HIMS) to distribute its weight-loss therapy Wegovy (semaglutide), Hims & Hers Health CEO Andrew Dudum said that ...
Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results